Literature DB >> 29143396

Sustained release of stem cell factor in a double network hydrogel for ex vivo culture of cord blood-derived CD34+ cells.

Yuanhao Zhang1, Xiuwei Pan1, Zhen Shi1, Haibo Cai1, Yun Gao1, Weian Zhang1.   

Abstract

OBJECTIVES: Stem cell factor (SCF) is considered as a commonly indispensable cytokine for proliferation of haematopoietic stem cells (HSCs), which is used in large dosages during ex vivo culture. The work presented here aimed to reduce the consumption of SCF by sustained release but still support cells proliferation and maintain the multipotency of HSCs.
MATERIALS AND METHODS: Stem cell factor was physically encapsulated within a hyaluronic acid/gelatin double network (HGDN) hydrogel to achieve a slow release rate. CD34+ cells were cultured within the SCF-loaded HGDN hydrogel for 14 days. The cell number, phenotype and functional capacity were investigated after culture.
RESULTS: The HGDN hydrogels had desirable properties and encapsulated SCF kept being released for more than 6 days. SCF remained the native bioactivity, and the proliferation of HSCs within the SCF-loaded HGDN hydrogel was not affected, although the consumption of SCF was only a quarter in comparison with the conventional culture. Moreover, CD34+ cells harvested from the SCF-loaded HGDN hydrogels generated more multipotent colony-forming units (CFU-GEMM).
CONCLUSION: The data suggested that the SCF-loaded HGDN hydrogel could support ex vivo culture of HSCs, thus providing a cost-effective culture protocol for HSCs.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29143396      PMCID: PMC6528907          DOI: 10.1111/cpr.12407

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  42 in total

1.  3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche.

Authors:  Isabelle Leisten; Rafael Kramann; Mónica S Ventura Ferreira; Manfred Bovi; Sabine Neuss; Patrick Ziegler; Wolfgang Wagner; Ruth Knüchel; Rebekka K Schneider
Journal:  Biomaterials       Date:  2011-12-01       Impact factor: 12.479

2.  Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion.

Authors:  Gerard J Madlambayan; Ian Rogers; Daniel C Kirouac; Nobuko Yamanaka; Frèdèric Mazurier; Monica Doedens; Robert F Casper; John E Dick; Peter W Zandstra
Journal:  Exp Hematol       Date:  2005-10       Impact factor: 3.084

3.  Double-Network-Structured Graphene Oxide-Containing Nanogels as Photothermal Agents for the Treatment of Colorectal Cancer.

Authors:  Calogero Fiorica; Nicolò Mauro; Giovanna Pitarresi; Cinzia Scialabba; Fabio S Palumbo; Gaetano Giammona
Journal:  Biomacromolecules       Date:  2017-02-20       Impact factor: 6.988

4.  Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with stromal support.

Authors:  Mónica S Ventura Ferreira; Willi Jahnen-Dechent; Norina Labude; Manfred Bovi; Thomas Hieronymus; Martin Zenke; Rebekka K Schneider; Sabine Neuss; Sabine Neurs
Journal:  Biomaterials       Date:  2012-07-15       Impact factor: 12.479

5.  Space constraints govern fate of hematopoietic stem and progenitor cells in vitro.

Authors:  Eike Müller; Tatyana Grinenko; Tilo Pompe; Claudia Waskow; Carsten Werner
Journal:  Biomaterials       Date:  2015-03-26       Impact factor: 12.479

6.  Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells.

Authors:  Thomas Walenda; Gudrun Bokermann; Mónica S Ventura Ferreira; Daniela M Piroth; Thomas Hieronymus; Sabine Neuss; Martin Zenke; Anthony D Ho; Albrecht M Müller; Wolfgang Wagner
Journal:  Exp Hematol       Date:  2011-02-26       Impact factor: 3.084

7.  CD29 of human umbilical cord mesenchymal stem cells is required for expansion of CD34(+) cells.

Authors:  Y Yang; M Hu; Y Zhang; H Li; Z Miao
Journal:  Cell Prolif       Date:  2014-09-18       Impact factor: 6.831

8.  Human stem cell factor (SCF) is a heparin-binding cytokine.

Authors:  Satoko Kishimoto; Shingo Nakamura; Hidemi Hattori; Shin-Ichiro Nakamura; Fumie Oonuma; Yasuhiro Kanatani; Yoshihiro Tanaka; Yasutaka Mori; Yasuji Harada; Masahiro Tagawa; Masayuki Ishihara
Journal:  J Biochem       Date:  2008-12-12       Impact factor: 3.387

9.  The use of covalently immobilized stem cell factor to selectively affect hematopoietic stem cell activity within a gelatin hydrogel.

Authors:  Bhushan P Mahadik; Sara Pedron Haba; Luke J Skertich; Brendan A C Harley
Journal:  Biomaterials       Date:  2015-07-23       Impact factor: 12.479

10.  Optimization of SCF feeding regimen for ex vivo expansion of cord blood hematopoietic stem cells.

Authors:  Zheng Du; Haibo Cai; Zhaoyang Ye; Wen-Song Tan
Journal:  J Biotechnol       Date:  2012-08-29       Impact factor: 3.307

View more
  2 in total

1.  Sustained release of stem cell factor in a double network hydrogel for ex vivo culture of cord blood-derived CD34+ cells.

Authors:  Yuanhao Zhang; Xiuwei Pan; Zhen Shi; Haibo Cai; Yun Gao; Weian Zhang
Journal:  Cell Prolif       Date:  2017-11-15       Impact factor: 6.831

2.  Stimulation of C-Kit+ Retinal Progenitor Cells by Stem Cell Factor Confers Protection Against Retinal Degeneration.

Authors:  Xi Chen; Shanshan Li; Xiaoli Liu; Jingjie Zhao; Lanting Wu; Ran You; Yanling Wang
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.